RE:RE:RE:RE:May will be better than April not the way I see it. SZLS was obviously been waiting for something. The FDA has never seen a test like Aristotle before and made a decision IMO to require an Oncologyist be involved. Did Stage want it to be like this. Probably not. They sell their other cancer tests with a Telehealth prescription Doctor order and not a problem. Sellig Aristotle the same way is a whole different story. No way a novel pan cancer test for multi cancers is even remotely the same. This is brand new territory. First to market. Szls is breaking new ground here. The competition is watching. That you can be sure of.